Buy Lumigan
Lumigan

$55.39
Category
Active Ingredient
Delivery
Airmail (14-21 days) | EMS trackable (5-9 days)
Prescription
Issued on site / Included
Availability
In Stock
Product is shipped in a fully discreet envelope with no content disclosure, including all required documentation inside

Lumigan Properties

Active Ingredients
Primary Category
Pharmacological Class
Prostaglandin Analog
Minor Side Effects
Dosage Forms
Eye Drops
Administration Route
Topical (Eye)
Mechanism of Action
Reduces pressure inside the eye by increasing the natural flow of fluid out of the eye. This helps protect the optic nerve from damage in glaucoma.
Prescription Status
Rx
Manufacturer
Allergan
Patient Summary
Used to lower high pressure inside the eye. This helps manage conditions like glaucoma and ocular hypertension to prevent vision loss.
Onset Time
Generally within hours.
Duration
About 24 hours.
Storage Instructions
Store at room temperature.
Age Restrictions
Use in children depends on the condition, consult doctor.
Pregnancy Use
Consult doctor before use during pregnancy or breastfeeding.
Alternative Drugs

About Lumigan

Lumigan (bimatoprost) is a prescription-only eye drop primarily approved in Australia for the reduction of intra-ocular pressure in patients with open-angle glaucoma or ocular hypertension. The medication belongs to the prostaglandin-analog class and works by enhancing fluid outflow from the eye, helping to prevent optic nerve damage. While its main indication is eye-pressure control, clinicians sometimes consider it for other ophthalmic uses under specialist supervision.

What is Generic Lumigan (Bimatoprost)?

Generic Lumigan (Bimatoprost) is the branded form of bimatoprost .03 % ophthalmic solution, packaged in a single-use 3 ml bottle. It is regulated by the Therapeutic Goods Administration (TGA) and has been listed on the Australian Pharmaceutical Benefits Scheme (PBS) since 2005. The product is classified as a prostaglandin-F-receptor agonist and is indicated for the management of elevated intra-ocular pressure in primary open-angle glaucoma and ocular hypertension. Its safety profile and efficacy have been confirmed in multiple Phase III trials conducted in Australia and overseas.

How Lumigan Works

Lumigan contains bimatoprost, a synthetic analogue of prostaglandin F₂α. After topical application, the molecule penetrates the corneal epithelium and binds to prostaglandin-F receptors located in the ciliary body and trabecular meshwork. This binding triggers a cascade that remodels the extracellular matrix, ultimately widening the uveoscleral outflow pathways. As a result, aqueous humour drains more efficiently, leading to a sustained reduction in intra-ocular pressure-typically a 25-30 % drop from baseline within 12 hours of a single dose. The drug’s half-life in the aqueous humour is approximately 45 minutes, but its pharmacodynamic effect persists for several days, allowing once-daily dosing. Metabolism occurs mainly via hepatic oxidation, and systemic exposure is minimal because only trace amounts enter the bloodstream.

Why Lumigan is Used for Eye Care Conditions

  • Open-Angle Glaucoma - By increasing uveoscleral outflow, Lumigan directly counters the primary pathophysiological defect of impaired drainage, making it a first-line option in the Australian Glaucoma Guidelines.
  • Ocular Hypertension - Patients with elevated pressure but no optic-nerve damage benefit from the same mechanism, reducing the risk of progression to glaucoma.
  • Secondary Glaucoma (e.g., pseudoexfoliative) - Clinical observations show comparable pressure-lowering efficacy to other prostaglandin analogues, and guidelines list it as an acceptable alternative.
  • Adjunct Therapy - When target pressure is not reached with a single agent, adding Lumigan to a beta-blocker or carbonic anhydrase inhibitor often achieves the desired reduction without significant systemic side effects.

Compared with timolol (a beta-blocker), Lumigan provides greater pressure reduction with once-daily dosing and fewer systemic cardiovascular concerns. Relative to latanoprost, efficacy is similar, though individual response varies; some patients experience less conjunctival hyperemia with bimatoprost.

Off-Label and Investigational Uses of Lumigan

Small-scale studies have examined bimatoprost for promoting eyelash growth in patients with alopecia areata, and case series suggest modest benefits. However, these uses are not approved by the TGA in Australia, and the evidence remains limited to short-term trials. Off-label use should only be considered under the supervision of a qualified healthcare provider.

Is Lumigan Right for You?

Lumigan suits adults who have been diagnosed with open-angle glaucoma or ocular hypertension and require a reliable, once-daily pressure-lowering agent. It is particularly advantageous for patients who struggle with adherence to multiple-dose regimens. Caution is advised in pregnant or breastfeeding women (category C) and in individuals with a history of uveitis, as prostaglandin analogues can exacerbate intra-ocular inflammation. Patients with severe corneal pathology may also experience delayed healing. As noted in the medication information, renal or hepatic impairment does not significantly alter dosing, but clinicians should monitor for systemic side effects in vulnerable populations.

Taking Lumigan Effectively

  • Timing: Instill one drop into the affected eye(s) at the same time each evening, preferably after removal of contact lenses.
  • Technique: Pull down the lower eyelid to create a pocket, squeeze the bottle gently, and avoid touching the tip to the ocular surface to prevent contamination.
  • Food/Drink Interactions: None are clinically relevant because absorption is largely local.
  • Missed Dose: If a dose is forgotten, administer it as soon as remembered unless it is within two hours of the next scheduled dose; then skip the missed dose and resume the regular schedule.
  • Travel: Carry the bottle in a protective case; avoid exposing it to temperatures above 30 °C, which can degrade the active ingredient.

Understanding Side Effects and How to Manage Them

  • Conjunctival Hyperemia - The most common reaction, caused by vasodilation induced by prostaglandin receptor activation. Applying a cold compress for a few minutes can lessen redness.
  • Eyelash Changes - Longer, thicker lashes result from stimulation of hair-follicle receptors; usually not problematic but patients should trim lashes if they become irritating.
  • Iris Pigmentation - Progressive brownening of the iris occurs in a subset of patients due to melanin synthesis stimulation; this change is permanent and warrants counseling before initiation.
  • Periocular Darkening - Similar melanin activation can darken the skin around the eye; sunscreen and gentle skin care may reduce cosmetic impact.
  • Serious Reactions - Acute eye pain, blurred vision, or signs of uveitis require immediate medical attention, as they may indicate inflammation or infection unrelated to the drug’s mechanism.

Buying Lumigan from Our Online Pharmacy

Why Choose Our Service?

Access to prescription eye medication can be hindered by limited pharmacy stock or long waiting periods for specialist appointments. Through our platform, eligible adults can obtain Lumigan quickly, with discreet packaging that protects privacy.

Quality & Safety

Our pharmacy service collaborates with licensed Australian and international distributors who adhere to TGA-mandated Good Manufacturing Practices. Every bottle is sealed, tamper-evident, and accompanied by a full medication guide.

Pricing & Access

Because Lumigan is a high-cost branded product, our online pharmacy negotiates bulk purchasing agreements that often result in a 20 % reduction compared with retail pharmacy prices. We also list approved generic equivalents, enabling further savings for patients with PBS eligibility.

Discreet Delivery

Orders are processed within 24 hours. Express shipping arrives in about 7 days; standard shipments take up to 3 weeks. All parcels are packaged in unbranded, protective boxes to ensure confidentiality.

Frequently Asked Questions

  • What should I do if I accidentally get Lumigan in my other eye? Gently rinse the eye with sterile saline or clean water for several minutes. The excess will dilute quickly, and no lasting harm is expected.

  • Can I use Lumigan with other eye drops? Yes, but maintain a 5-minute interval between applications to avoid dilution and ensure each medication absorbs properly.

  • Will Lumigan interfere with my contact lenses? Remove contact lenses before instilling the drop and wait at least 15 minutes before reinserting them to prevent lens discoloration.

  • How long will it take to see a pressure reduction? Most patients experience a clinically meaningful drop in intra-ocular pressure within 12 hours, with peak effect around 24 hours after the first dose.

  • Is there any risk of systemic side effects? Systemic exposure is minimal; however, rare cases of headache or mild nausea have been reported, usually resolving without intervention.

  • Why does my iris appear darker after several weeks? Bimatoprost stimulates melanin production in the iris, leading to a gradual color change that is permanent once it occurs.

  • Can Lumigan be used for children? Current Australian guidelines limit its use to adults; pediatric applications lack sufficient safety data and are therefore not recommended.

  • What distinguishes Lumigan from other prostaglandin analogues? While all prostaglandin analogues increase uveoscleral outflow, bimatoprost (Lumigan) has a slightly higher affinity for its receptor, which can translate into a marginally greater pressure-lowering effect for some patients.

  • Is it safe to use Lumigan while pregnant? The medication is classified as category C; it should only be used if the potential benefit justifies the potential risk to the fetus, and this decision must be made by the treating ophthalmologist.

  • How often should I have my eye pressure checked after starting Lumigan? An initial follow-up visit is typically scheduled after 4-6 weeks to confirm target pressure has been achieved, then every 3-6 months thereafter, depending on disease stability.

Glossary

Prostaglandin-F-Receptor
A protein on ocular tissues that binds prostaglandin molecules, initiating signaling pathways that increase aqueous-humour outflow.
Uveoscleral Outflow
The secondary drainage route for aqueous humour that bypasses the trabecular meshwork, accounting for 20-30 % of total fluid clearance.
Intra-Ocular Pressure (IOP)
The fluid pressure inside the eyeball; elevated IOP is the primary risk factor for optic nerve damage in glaucoma.
Hyperemia
Redness of the conjunctiva caused by vasodilation, commonly observed as a side effect of prostaglandin analogues.
Iridology Pigmentation
The darkening of the iris that can occur with long-term use of certain eye drops, resulting from increased melanin synthesis.

Disclaimer

The information provided about Lumigan is for general knowledge only and does not replace professional medical consultation. All treatment decisions, including those regarding off-label use, should be made under the supervision of a qualified healthcare provider. We assume readers are responsible adults capable of making informed health decisions. Our online pharmacy offers access to Lumigan for individuals who may have limited availability through traditional pharmacies, prescription-based insurance schemes, or who are seeking affordable generic alternatives. Always consult your doctor before starting, changing, or discontinuing any medication.

External Resources about Lumigan


Information Prepared By

Sarah Jones
Tosin (Olalekan) Olaluwoye, MD, PhD